These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 34369166)
1. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166 [TBL] [Abstract][Full Text] [Related]
2. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials. Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464 [TBL] [Abstract][Full Text] [Related]
3. The impact of colchicine on patients with acute and chronic coronary artery disease. Madanchi M; Young M; Tersalvi G; Maria Cioffi G; Attinger-Toller A; Cuculi F; Kurmann R; Bossard M Eur J Intern Med; 2024 Jul; 125():1-9. PubMed ID: 38238134 [TBL] [Abstract][Full Text] [Related]
4. Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis. Shrestha DB; Budhathoki P; Sedhai Y; Khadka M; Pokharel S; Yadav S; Patel T; Elgendy I; Mir WAY; Patel NK J Cardiovasc Pharmacol; 2022 Apr; 79(4):420-430. PubMed ID: 34935703 [TBL] [Abstract][Full Text] [Related]
5. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials. Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials. Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ; Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634 [TBL] [Abstract][Full Text] [Related]
7. Colchicine therapy in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Al-Abdouh A; Barbarawi M; Khan SU; Osman M; Upadhrasta S; Solipuram V; Abusnina W; Radaideh Q; Zhao D; Michos ED Coron Artery Dis; 2021 Aug; 32(5):441-447. PubMed ID: 32732517 [TBL] [Abstract][Full Text] [Related]
8. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials. Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease. Chen T; Liu G; Yu B Clin Res Cardiol; 2023 Nov; 112(11):1487-1505. PubMed ID: 37505274 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients. Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702 [TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease. Akl E; Sahami N; Labos C; Genest J; Zgheib A; Piazza N; Jolly S J Interv Cardiol; 2024; 2024():8646351. PubMed ID: 38505729 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Jolly SS; Keech AC; Kelly P; Tong DC; Layland J; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH Eur Heart J; 2021 Jul; 42(28):2765-2775. PubMed ID: 33769515 [TBL] [Abstract][Full Text] [Related]
14. Colchicine administration for percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Fu C; Wang B Am J Emerg Med; 2021 Aug; 46():121-125. PubMed ID: 33744748 [TBL] [Abstract][Full Text] [Related]
16. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis. Goh CXY; Tan YK; Tan CH; Leow AST; Ho JSY; Tan NHW; Goh S; Ho AFW; Sharma VK; Chan BPL; Yeo LLL; Tan BYQ J Thromb Thrombolysis; 2022 Jul; 54(1):183-190. PubMed ID: 35538274 [TBL] [Abstract][Full Text] [Related]
17. Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials. Sethuramalingam S; Maiti R; Hota D; Srinivasan A Am J Ther; 2023 May; 30(3):e197-e208. PubMed ID: 34264887 [TBL] [Abstract][Full Text] [Related]
18. Role of Colchicine in Stroke Prevention: An Updated Meta-Analysis. Masson W; Lobo M; Molinero G; Masson G; Lavalle-Cobo A J Stroke Cerebrovasc Dis; 2020 May; 29(5):104756. PubMed ID: 32160956 [TBL] [Abstract][Full Text] [Related]
19. Colchicine for cardiovascular medicine: a systematic review and meta-analysis. Casula M; Andreis A; Avondo S; Vaira MP; Imazio M Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease. Xia M; Yang X; Qian C Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]